Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: A phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)

Kenneth I. Ataga, Marvin Reid, Samir K. Ballas, Zahida Yasin, Carolyn Bigelow, Luther St James, Wally R. Smith, Frederic Galacteros, Abdullah Kutlar, James H. Hull, Jonathan W. Stocker

Research output: Contribution to journal › Article › peer-review

172 Scopus citations

Fingerprint

Dive into the research topics of 'Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: A phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapoc (ICA-17043)'. Together they form a unique fingerprint.

Medicine & Life Sciences